Alerus Financial Corp <ALRS.O>: Piper Sandler raises target price to $37 from $32
ALRS•Related News
Neurocrine Biosciences, Inc <NBIX.O>: Baird raises target price to $225 from $186
NBIX•
Primerica HBI shows middle-income purchasing power rises to 100.1% in June as gas prices fall
PRI•
HSBC survey shows affluent investors cut cash allocation to 19% in 2026 from 33% in 2024
HSBC•
Columbus McKinnon Corp <CMCO.O>: JP Morgan raises target price to $29 from $25
CMCO•
Us Regulators Cite ‘Circular’ Risk In Investments Used By KKR And Apollo- FT
APO•